Anebulo Pharmaceuticals, Inc. (OTCPK: ANEB)
Health Care · Pharmaceuticals · US
$0.32
-1.56% today · -86.4% 1Y
Anebulo Pharmaceuticals, Inc. (OTCPK: ANEB) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $12.85M and employs 3 people.
Over the last twelve months the share price has lost 86.4%, trading between 0.00 and 2.85.
Tweenvest scores Anebulo Pharmaceuticals, Inc. across four factors: quality 35/100, value 21/100. Its strongest factor is quality.
ANEB price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $12.85M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.19
- Dividend yield
- —
- Beta (5Y)
- -1.89
- 52-week high
- $2.85
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 40.78M
- Employees
- 3
- Next earnings
- —
About Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. The company’s lead product candidate is the selonabant, a small-molecule antagonist of cannabinoid binding receptor type-1(CB1), which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Lakeway, Texas.
- ISIN
- US0345691036
- Founded
- 2020
- Listed since
- May 7, 2021
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Klaria Pharma Holding AB (publ.)OM: KLAR | $13.36M | Skr0.54 | -8.12% |
| Ayr Wellness Inc.CNSX: AYR.A | $13.21M | CA$— | — |
| Indo-Bangla Pharmaceuticals LimitedDSE: IBP | $13.02M | Tk13.80 | -5.48% |
| Silco Pharmaceuticals LimitedDSE: SILCOPHL | $12.90M | Tk15.30 | -8.38% |
| Intravenous Infusions PlcGHSE: IIL | $12.84M | GH₵0.55 | +12.24% |
| FLUENT Corp.CNSX: FNT.U | $12.76M | $0.02 | -20.00% |
| Biogened S.A.WSE: BGD | $12.41M | zł19.80 | +0.51% |
| Krebs Biochemicals & Industries LimitedBSE: 524518 | $12.41M | Rs55.72 | -19.71% |
Figures last refreshed Oct 11, 2026.